Miraklide (Escitalopram)

Escitalopram, the active ingredient in Miraklide, is a selective serotonin reuptake inhibitor presented as an oral dosage form for oral use. It is prescribed for major depressive disorder and several anxiety disorders in adult patients. GNH USA supplies Miraklide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Escitalopram belongs to the SSRI class and is used to treat mood and anxiety disorders by enhancing serotonergic neurotransmission. - Major depressive disorder: reduces depressive symptoms and improves functional recovery. - Generalized anxiety disorder: alleviates excessive worry and physical tension. - Social anxiety disorder: decreases fear of social situations and improves social functioning. - Panic disorder: lowers frequency and severity of panic attacks.

Escitalopram may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: mild gastrointestinal upset often occurring early in therapy. - Headache: transient tension‑type headache. - Insomnia or somnolence: sleep disturbances or increased drowsiness. - Dry mouth: reduced salivation. - Sexual dysfunction: decreased libido or delayed orgasm.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, tremor, and autonomic instability. - Suicidal thoughts: emergence of suicidal ideation, especially in young adults. - Severe allergic reaction: rash, swelling, or anaphylaxis. - QT interval prolongation: cardiac rhythm disturbances. - Hyponatremia: low blood sodium, particularly in elderly patients.

Before initiating therapy, clinicians should consider several safety measures. - Monitor mood: watch for worsening depression or emergence of suicidal thoughts. - Assess hepatic function: dose adjustment may be needed in liver impairment. - Caution in elderly: increased sensitivity to side effects such as hyponatremia. - Avoid abrupt discontinuation: taper gradually to reduce withdrawal symptoms. - Review concomitant serotonergic agents: evaluate risk of serotonin syndrome. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Escitalopram can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome; a 14‑day washout is required. - Pimozide: can cause QT prolongation and arrhythmias. - Thioridazine: increased risk of cardiac toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs or anticoagulants: heightened bleeding risk. - Carbamazepine: may reduce escitalopram plasma levels. - Alcohol: can enhance central nervous system depression. - Other serotonergic agents (e.g., tramadol): monitor for serotonin syndrome.